Coagulation Modifiers Flashcards

1
Q

What are the steps in the
Blood Vessel Injury Healing Process?

Blood coagulation/clotting process

A
  • Local vasoconstriction to seal off small injury (makes surface area of injury smaller)
  • Platelet aggregation forms a platelet plug
  • Hageman factor is activated (clotting factor)
  • Intrinsic pathway (inside the vessel) converts prothrombin to thrombin to seal system
  • Extrinsic pathway (outside the vessel) clots the blood that has leaked out of the vascular system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lifespan Considerations for Coagulation Modifiers
In Children

A
  • Most common: Antihemophiliac agents for children with hemophilia
  • Injury and safety precautions: no contact sports, soft toothbrushes, no flossing
  • Teach what to do if bleeding begins: constant firm pressure, call provider
  • Drugs are based on weight and age
  • Low-molecular weight heparins preferred
  • Monitor closely
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lifespan Considerations for Coagulation Modifiers
In Adults

A
  • Injury prevention: soft bristled toothbrush, no flossing, electric razor, no contact sports
  • What to do if bleeding begins: constant firm pressure, call provider
  • Caution with other meds due to interactions
  • Medic Alert bracelet
  • Extreme caution in pregnancy and lactation; choose alternate feeding method
  • Periodic blood tests (less testing with newer meds)
  • Monitor for signs of bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lifespan Considerations for Coagulation Modifiers
In Older Adults

A
  • Look closely for drug interactions
  • Impaired liver and kidney function: run liver and kidney function tests
  • Start low, go slow
  • Safety and Injury Prevention: Fall prevention, electric razors, soft toothbrush, no flossing
  • Careful monitoring with additions, deletions, or changes to medication regimen (including dose changes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Antiplatelet Agents
Mechanism of Action

A

Alters the formation of the platelet plug
* Blocks the receptor site on the platelet membrane which prevents platelets from sticking together and clumping (aggregating)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antiplatelet Agents
Indications

A
  • CV diseases that are prone to clogged vessels
  • Keep surgical grafts open/patent
  • Prevent cerebrovascular occlusion (strokes and TIAs)
  • Adjunct to thrombolytic therapy after MI and to prevent another MI
  • Aspirin: Antiinflammatory, antipyretic, analgesic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antiplatelet Agents
Drug Names

A

Aspirin
Clopidogrel
Ticagrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antiplatelet Agents
Contraindications

A

Absolute:
* Allergy

Cautions:
* Bleeding disorder (higher risk of bleeding)
* Recent surgery
* Closed-head injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antiplatelet Agents
Adverse Effects

A

🩸 BLEEDING: major effect! Monitor for black stools, bruising, petechiae, epistaxis
🧠 CNS: Headache, dizziness, weakness
🤢 GI: Nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antiplatelet Agents
Drug Interactions

A
  • Another drug that affects blood clotting
  • Herbal supplements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antiplatelet Agents
Assessment

A

History:
* Allergy, pregnancy, lactation, bleeding disorders, recent surgery, closed head injury

Physical:
* vitals, skin, CNS, perfusion

Labs:
* CBC
* Clotting studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antiplatelet Agents
Nursing Diagnoses/Conclusions

A
  • Injury Risk (r/t CNS and bleeding effects)
  • Impaired comfort (r/t GI effects)
  • Knowledge deficit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antiplatelet Agents
Implementation/Patient Teaching

A
  • Safety precautions: electric razors, soft toothbrush, no flossing, no contact sports
  • Small, frequent meals for GI effects
  • Increased precautions for bleeding during invasive procedures
  • Mark the chart of any patient receiving this drug
  • Ice and pressure can help stop bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anticoagulant Agents
Mechanism of Action

A
  • Interferes with the normal cascade of events involved in the clotting process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anticoagulant Agents
Indications

A

Prevent new clot formation
* Atrial fibrilation
* Bed Bound
* Certain surgical patients

Prevent existing clots from getting bigger
* Deep vein thrombosis (DVT)
* Pulmonary Embolism (PE)
* Myocardial Infarction (MI)

Genetic disorders
(missing part of the clotting cascade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anticoagulant Agents
Drug Names

A

Warfarin
Heparin
“-xaban”
Rivaroxaban
Apixaban
Dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anticoagulant Agents
Contraindications

A

Absolute:
* Allergy

Relative:
* conditions that would be worsened if bleeding occurs (recent trauma, GI ulcers, spinal puncture)

Cautions:
* Renal & hepatic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anticoagulant Agents
Adverse Effects

A

🩸 Excessive bleeding
* priapism
* Increased menstrual flow
* Black tarry stools
* Epistaxis

Heparin-induced thrombocytopenia (HIT): “allergy” to heparin - can never have heparin again

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Anticoagulant Agents
Drug Interactions

A

Any drug that affects bleeding
* NSAIDs/Salicylates
* Antiplatelets
* Thrombolytics

Herbal Supplements (can increase bleeding)

NUMBER of many drug interactions Check drug guide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Anticoagulant Agents
Assessment

A

History:
* Allergy, pregnancy, lactation
* Conditions that would be worsened if bleeding occurs

Physical:
* Vitals, heart sounds, lung sounds, skin, CNS, orientation, perfusion

Labs:
* CBC (Hgb, Hct)
* Clotting studies
* Renal and hepatic function tests
* guaiac test for blood in stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anticoagulant Agents
Nursing Diagnoses/Conclusions

A
  • Injury risk (r/t bleeding)
  • Altered tissue perfusion (r/t blood loss)
  • Altered cardiac output (r/t blood loss)
  • Disturbed body image (r/t skin changes… bruising)
  • Knowledge deficit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Anticoagulant Agents
Implementation/Patient Teaching

A
  • Check lab values during treatment
  • Monitor for signs of blood loss (epistaxis, petechiae, neuro status for brain bleed)
  • Establish safety precautions: electric razor, soft toothbrush, no contact sports
  • Increase bleeding precautions during invasive procedures
  • Mark chart of patient receiving this drug
  • Maintain antidotes on standby:
    Warfarin: Vitamin K
    Heparin: Protamine sulfate
  • Monitor patient carefully when change in medication
  • Ice, pressure for bleeding
  • Wear medic alert bracelet
  • Keep follow up appts.
  • Teach patient to report bleeding to provider
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Therapeutic value to watch with Warfarin

A

INR: 2-3
(higher than a normal value because of treatment)

24
Q

Therapeutic values to watch with Heparin

A
  • aPTT 60-80
  • anti-Xa (anti-10A)
25
Q

Low-Molecular-Weight Heparins (LMWH)
Mechanism of action

A
  • Inhibit thrombus and clot formation by blocking factors Xa and IIa (10a and 2a)
  • Do NOT greatly affect thrombin, clotting, or prothrombin times = fewer systemic adverse effects
  • Block angiogenesis, the process that allows cancer cells to develop new blood vessels

Longer half-life than other anticoagulants = longer lasting effects

26
Q

Low-Molecular-Weight Heparins (LMWH)
Indications

A
  • Specific uses in the prevention of clots and emboli formation after certain surgeries or while on bed rest
27
Q

Low-Molecular-Weight Heparins (LMWH)
Drug Names

A

Dalteparin
Enoxaparin

28
Q

Thrombolytic Agents (AKA: Clot Busters)
Mechanism of Action

A

Activates plasminogen to plasmin, which in turn breaks down fibrin threads in a clot to dissolve it

29
Q

Thrombolytic Agents (AKA: Clot Busters)
Indications

A
  • Acute MI
  • Pulmonary emboli
  • Ischemic stroke
30
Q

Thrombolytic Agents (AKA: Clot Busters)
Drug Names

A

“-teplase”
Alteplase
Reteplase
Tenecteplase

31
Q

Thrombolytic Agents (AKA: Clot Busters)
Contraindications

A

Absolute:
* Allergy

Cautions:
* Any condition worsened by dissolution of clots (recent surgery, trauma, recent stroke, GI bleed, recent childbirth)
* Liver disease

32
Q

Thrombolytic Agents (AKA: Clot Busters)
Adverse Effects

A

🩸 Bleeding

33
Q

Thrombolytic Agents (AKA: Clot Busters)
Drug Interactions

A
  • Anticoagulants
  • Antiplatelets

(increased bleeding)

34
Q

Thrombolytic Agents (AKA: Clot Busters)
Assessment

A

History:
* Allergy, pregnancy, lactation
* Conditions that would be worsened if bleeding occurs

Physical:
* Baseline: vitals, heart sounds, lung sounds, skin, CNS, perfusion

Labs:
* clotting studies
* Renal and hepatic function tests
* CBC
* guaiac stool test

35
Q

Thrombolytic Agents (AKA: Clot Busters)
Implementation/Patient Teaching

A
  • Discontinue heparin if it is being given before administering a thrombolytic agent
  • Check lab values
  • Monitor for signs of blood loss (epistaxis, blood in stool, petechiae, surgical sites, IV sites)
  • Institute treatment within 6 hours after onset of symptoms of acute MI
  • Arrange to type and cross-match blood to have on hand
  • Monitor cardiac rhythm continuously if the drug is being given for acute MI
  • Increase bleeding precautions during invasive procedures
  • Mark chart if patient is receiving this drug
  • Ideally wait 24 hours after thrombolytic admin to do any type of invasive procedure
36
Q

Hemorrheologic Agent: Pentoxifylline
Mechanism of Action

A
  • Xanthine that decreases platelet aggregation and decreases fibrinogen concentration in the blood

Helps blood flow in compromised blood vessels

37
Q

Hemorrheologic Agent: Pentoxifylline
Indication

A

Intermittent claudication

38
Q

Hemorrheologic Agent: Pentoxifylline
Adverse Effects

A

💓 Many CV stimulatory effects
* racing heart/palpitations
* anxiety
* flushing
* angina

39
Q

What are bleeding disorders treated with Clotting Factors?

A
  • Hemophilia
  • Liver Disease
  • Bone Marrow Disorders
40
Q

Antihemophilics
Mechanism of Action

A
  • Replace clotting factors that are either genetically missing or low in a particular type of hemophilia
41
Q

Antihemophilics
Indications

A
  • Prevent blood loss from injury or surgery and to treat bleeding disorders
42
Q

Antihemophilics
Drug Names

A

“factor”
All medications in this category have the word factor in their name

43
Q

Antihemophilics
Contraindications

A

Absolute:
* Anaphylactic Allergy

44
Q

Antihemophilics
Adverse Effects

A

Involve risks associated with the use of blood products
* Infections such as hepatitis
* Headache, flushing, fever, chills, lethargy
* Stinging, itching, burning at the site of injection

45
Q

Antihemophilics
Assessment

A

History:
* Allergy, pregnancy, lactation

Physical:
* Skin, heart and lung sounds, CNS, perfusion, vital signs

Labs:
* clotting studies

46
Q

Antihemophilics
Nursing Diagnoses/Conclusions

A
  • Altered tissue perfusion (r/t changes in coagulation)
  • Impaired comfort (r/t CNS, skin, or injection site)
  • Anxiety or fear
  • Knowledge deficit
47
Q

Antihemophilics
Implementation/Patient Teaching

A
  • Ensure the appropriate clotting factor is being used for the patient
  • Administered by IV route ONLY
  • Check lab values (clotting studies)
  • Monitor pt for any sign of thrombosis (clots)
  • Decrease infusion rate if headache, chills, fever, or tingling occurs
  • Arrange to type and cross-match blood and have onhand
  • Mark the chart of any patient receiving this drug
48
Q

Hemostatic Agents
Mechanism of Action

A

Systemic
Prevent systemic clot breakdown to prevent blood loss
Topical
For surface injuries involving so much damage to the small vessels in the area that clotting does not occur and blood is slowly and continually lost

49
Q

Hemostatic Agents
Indication

A

Hyperfibrinolysis = hyper clot breakdown

50
Q

Hemostatic Agents
Drug Names

A

Systemic
Aminocaproic Acid (oral or IV)
Topical
Absorbable gelatin
collagen
fibrin
thrombin
(sponges, sprays, topical)

51
Q

Hemostatic Agents
Contraindications

A

Absolute:
Systemic:
* Allergy
* Acute disseminated intravascular coagulation (DIC) = clotting and bleeding at the same time

Topical:
* Allergy

Cautions:
Systemic:
* Cardiac, renal, or hepatic disease

Topical:
* NONE

52
Q

Hemostatic Agents
Adverse Effects

A

Systemic
* Excessive clotting, CNS, GI, weakness, fatigue, malaise, muscle pain

Topical
* Infection with sponges

53
Q

Hemostatic Agents
Drug Interactions

A

Systemic:
* Heparin, oral contraceptives/estrogen

Topical:
* NONE

54
Q

Hemostatic Agents
Assessment

A

History:
* Allergy, pregnancy, lactation, cardiac, renal or hepatic dysfunction

Physical:
* skin, heart and lung sounds, CNS, perfusion, abdominal assessment, vital signs

Labs:
* clotting studies, renal function tests, hepatic function tests

55
Q

Hemostatic Agents
Nursing Diagnoses/Conclusions

A
  • Altered sensory perception (r/t CNS effects)
  • Impaired Comfort (r/t GI, CNS, muscle effects)
  • Injury Risk (r/t CNS, blood clotting)
  • Knowledge deficit
56
Q

Antidote for Warfarin

A

Vitamin K

57
Q

Antidote for He🅿️arin

A

🅿️rotamine sulfate